ClinicalTrials.Veeva

Menu

Effect of Probiotic Formula DE111® on Immune System in Preschool Children (IMMUNOFORM)

D

Deerland Probiotics & Enzymes

Status

Completed

Conditions

Immune System Support

Treatments

Dietary Supplement: Placebo comparator
Dietary Supplement: Probiotic Formula Bacillus subtilis DE111®

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04077034
IMMUNO-01

Details and patient eligibility

About

Healthy preschool children will be recruited, gastrointestinal infection and respiratory infection symptoms will be followed during the 8-week treatment and 4-week follow-up period, to evaluate the effect of the used probiotic formula on immune system in comparison to the group using placebo.

Enrollment

102 patients

Sex

All

Ages

2 to 6 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • signed informed consent by at least one parent or legal guardian
  • children aged 2 to 6 years
  • attending or about to start attending day-care

Exclusion criteria

  • body weight at birth <2500g
  • gestational age <37 weeks
  • severe chronic illness
  • regular use of medication
  • immunodeficiency
  • parent or legal guardian not able to understand and comply with requirements of the study

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

102 participants in 2 patient groups, including a placebo group

Experimental group
Experimental group
Description:
Probiotic DE111®
Treatment:
Dietary Supplement: Probiotic Formula Bacillus subtilis DE111®
Control group
Placebo Comparator group
Description:
Placebo
Treatment:
Dietary Supplement: Placebo comparator

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems